Strategic analysis on medical device regulation, FDA pathways, and compliance engineering.
12 Publications
When bringing a medical device to market, most teams instinctively default to the 510(k) pathway because it feels familiar. It is the option everyone knows, the one advisors mention first, and the ...
A medical device regulatory strategy is not something you “figure out later.” It is the framework that determines whether your device can realistically reach the market, how long that process will ...
Most people assume regulatory work is slow because the rules are hard.
If you build medical devices, you will build a quality management system whether you call it that or not.
Choosing a sterilization method is one of those “small” decisions that quietly controls your materials, packaging, test plan, and ultimately your FDA submission risk. If you pick the wrong method, ...
For most low-risk medical devices, regulatory success is not determined by whether FDA clearance is possible, but by how the regulatory pathway is framed from the beginning. Pathway selection influ...
Medical device labeling and Instructions for Use (IFU) are often treated as downstream documentation tasks—something finalized after pathway selection, predicate identification, and testing decisio...
Intended use and indications for use are two of the most misunderstood concepts in medical device regulation. They are often treated as interchangeable, but they serve different regulatory purposes...
Bringing a medical device to market does not end with FDA authorization. For manufacturers seeking hospital adoption, reimbursement strategy often becomes the next critical bottleneck. Even clinica...
Bringing a medical device to market is not simply a question of whether it will be cleared, approved, or authorized, but how you get there. Regulatory pathway selection, device classification, and ...
Early engagement with the FDA can shape the success or failure of a medical device submission long before a 510(k), De Novo, or PMA is filed. The FDA’s Pre-Submission and Q-Submission programs are ...
The FDA’s Electronic Submission Template and Resource (eSTAR) has fundamentally changed how 510(k) submissions are prepared, validated, and reviewed. What was once a largely document-driven process...